AZTA
Price
$30.85
Change
+$0.67 (+2.22%)
Updated
Sep 11 closing price
Capitalization
1.35B
66 days until earnings call
Intraday BUY SELL Signals
IART
Price
$15.50
Change
-$0.04 (-0.26%)
Updated
Sep 11 closing price
Capitalization
1.21B
53 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AZTA vs IART

AZTA vs IART Comparison Chart in %
View a ticker or compare two or three
VS
AZTA vs. IART commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Hold and IART is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($1.35B) has a higher market cap than IART($1.21B). IART has higher P/E ratio than AZTA: IART (66.48) vs AZTA (42.43). IART YTD gains are higher at: 24.799 vs. AZTA (-7.246). IART has higher annual earnings (EBITDA): 245M vs. AZTA (32.9M). AZTA has more cash in the bank: 326M vs. IART (274M). AZTA has less debt than IART: AZTA (54M) vs IART (2.05B). IART has higher revenues than AZTA: IART (1.65B) vs AZTA (614M).
AZTAIARTAZTA / IART
Capitalization1.35B1.21B112%
EBITDA32.9M245M13%
Gain YTD-7.24624.799-29%
P/E Ratio42.4366.4864%
Revenue614M1.65B37%
Total Cash326M274M119%
Total Debt54M2.05B3%
FUNDAMENTALS RATINGS
AZTA vs IART: Fundamental Ratings
AZTA
IART
OUTLOOK RATING
1..100
7259
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
83
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9391
PRICE GROWTH RATING
1..100
4248
P/E GROWTH RATING
1..100
846
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (47) in the Electronic Production Equipment industry is somewhat better than the same rating for IART (83) in the Medical Specialties industry. This means that AZTA’s stock grew somewhat faster than IART’s over the last 12 months.

AZTA's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as IART (100) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to IART’s over the last 12 months.

IART's SMR Rating (91) in the Medical Specialties industry is in the same range as AZTA (93) in the Electronic Production Equipment industry. This means that IART’s stock grew similarly to AZTA’s over the last 12 months.

AZTA's Price Growth Rating (42) in the Electronic Production Equipment industry is in the same range as IART (48) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to IART’s over the last 12 months.

IART's P/E Growth Rating (6) in the Medical Specialties industry is significantly better than the same rating for AZTA (84) in the Electronic Production Equipment industry. This means that IART’s stock grew significantly faster than AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTAIART
RSI
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
58%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
61%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 13 days ago
62%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 1 day ago
77%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
65%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
71%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (AZTA: $30.85 vs. IART: $15.50)
Brand notoriety: AZTA and IART are both not notable
AZTA represents the Pharmaceuticals: Other, while IART is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AZTA: 105% vs. IART: 89%
Market capitalization -- AZTA: $1.35B vs. IART: $1.21B
AZTA [@Pharmaceuticals: Other] is valued at $1.35B. IART’s [@Medical/Nursing Services] market capitalization is $1.21B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $130.41B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $1.86K to $176.41B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.43B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green while IART’s FA Score has 1 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • IART’s FA Score: 1 green, 4 red.
According to our system of comparison, both AZTA and IART are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 4 TA indicator(s) are bullish while IART’s TA Score has 4 bullish TA indicator(s).

  • AZTA’s TA Score: 4 bullish, 5 bearish.
  • IART’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both AZTA and IART are a bad buy in the short-term.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а -1.53% price change this week, while IART (@Medical/Nursing Services) price change was -7.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.51%. For the same industry, the average monthly price growth was -3.46%, and the average quarterly price growth was +12.67%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was -6.66%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 17, 2026.

IART is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-5.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
AZTA
Daily Signal:
Gain/Loss:
IART
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RWEBX67.020.28
+0.42%
American Funds Washington Mutual R-2E
JCNAX30.99N/A
N/A
Janus Henderson Contrarian A
PGICX19.54N/A
N/A
Virtus KAR Equity Income C
NAINX9.57N/A
N/A
Virtus Tactical Allocation A
VMFVX447.06N/A
N/A
Vanguard S&P Mid-Cap 400 Value Idx I